scholarly journals Vagus nerve stimulation for medically refractory epilepsy: A long-term follow-up study

Seizure ◽  
2007 ◽  
Vol 16 (7) ◽  
pp. 579-585 ◽  
Author(s):  
J.J. Ardesch ◽  
H.P.J. Buschman ◽  
L.J.J.C. Wagener-Schimmel ◽  
H.E. van der Aa ◽  
G. Hageman
2013 ◽  
Vol 3 (1) ◽  
pp. 16-20 ◽  
Author(s):  
Su Jung Choi ◽  
Seung Chyul Hong ◽  
Dae-Won Seo ◽  
Eun Yeon Joo ◽  
Jounhong Ryan Cho ◽  
...  

Seizure ◽  
2018 ◽  
Vol 59 ◽  
pp. 41-47 ◽  
Author(s):  
Jan Chrastina ◽  
Zdeněk Novák ◽  
Tomáš Zeman ◽  
Jitka Kočvarová ◽  
Martin Pail ◽  
...  

Epilepsia ◽  
1994 ◽  
Vol 35 (3) ◽  
pp. 637-643 ◽  
Author(s):  
R. George ◽  
M. Salinsky ◽  
R. Kuzniecky ◽  
W. Rosenfeld ◽  
D. Bergen ◽  
...  

CNS Spectrums ◽  
2006 ◽  
Vol 11 (2) ◽  
pp. 143-148 ◽  
Author(s):  
James M. Martinez ◽  
Holly A. Zboyan

AbstractThis is the first case report of a patient who received long-term (69-month) adjunctive vagus nerve stimulation (VNS) therapy for treatment-resistant depression (TRD) and reached VNS battery end-of-service (EOS).The patient is a 41-year-old female with depression who entered a study of adjunctive VNS therapy for TRD. Her Hamilton Rating Scale for Depression (HAM-D) scores dropped from a mean of 33.5 (pre-implantation baseline period) to 16 at the end of the 12-week acute-phase treatment period, and then fluctuated from <7 (normal range) to scores in the moderately depressed range (∼20) during long-term follow-up. Three and one-half years after VNS implantation, the patient's HAM-D scores began to increase from a score of 18 to a peak score of 27 ∼ 16 months later (5-years post-implantation). The patient subsequently reported that she could no longer feel stimulation from the device and device interrogation 2 weeks later indicated battery EOS. The patient was hospitalized due to worsened depression, the pulse generator was replaced, and medication adjusted. HAM-D scores through the subsequent 9 months of followup returned to a pattern of fluctuations within the range noted during the long-term follow-up period prior to VNS battery EOS.


2012 ◽  
Vol 154 (12) ◽  
pp. 2237-2240 ◽  
Author(s):  
Gabriella Colicchio ◽  
Nicola Montano ◽  
Filomena Fuggetta ◽  
Fabio Papacci ◽  
Francesco Signorelli ◽  
...  

Epilepsia ◽  
2006 ◽  
Vol 47 (3) ◽  
pp. 556-562 ◽  
Author(s):  
Eija Ronkainen ◽  
Juha T. Korpelainen ◽  
Esa Heikkinen ◽  
Vilho V. Myllyla ◽  
Heikki V. Huikuri ◽  
...  

Seizure ◽  
2010 ◽  
Vol 19 (5) ◽  
pp. 264-268 ◽  
Author(s):  
Kazem Ghaemi ◽  
Alaa Eldin Elsharkawy ◽  
Reinhard Schulz ◽  
Matthias Hoppe ◽  
Tilman Polster ◽  
...  

2013 ◽  
Vol 71 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Murilo S. Meneses ◽  
Samanta F. B. Rocha ◽  
Cristiane Simão ◽  
Heraldo Nei Hardt Laroca dos Santos ◽  
Cleudi Pereira ◽  
...  

INTRODUCTION: Refractory epilepsy accounts for 20 to 30% of epilepsy cases and remains a challenge for neurologists. Vagus nerve stimulation (VNS) is an option for palliative treatment. OBJECTIVE: It was to study the efficacy and tolerability of VNS in patients implanted with a stimulator at the Curitiba Institute of Neurology (INC). METHODS: A case study of six patients with refractory epilepsy submitted to a VNS procedure at the INC in the last four years was described and discussed. RESULTS: Mean age at time of implantation was 29 years. Mean follow-up was 26.6 months. Seizure frequency decreased in all patients (40-50% (n=2) and >80% (n=4)). Three patients no longer required frequent hospitalizations. Two patients previously restricted to wheelchairs started to walk, probably because of improved mood. CONCLUSION: In this population, VNS proved to be a sound therapeutic option for treating refractory epilepsy.


Sign in / Sign up

Export Citation Format

Share Document